SK68298A3 - New quinoxalindione derivatives, their preparation and use in medicaments - Google Patents

New quinoxalindione derivatives, their preparation and use in medicaments Download PDF

Info

Publication number
SK68298A3
SK68298A3 SK682-98A SK68298A SK68298A3 SK 68298 A3 SK68298 A3 SK 68298A3 SK 68298 A SK68298 A SK 68298A SK 68298 A3 SK68298 A3 SK 68298A3
Authority
SK
Slovakia
Prior art keywords
group
trifluoromethyl
acid
optionally substituted
dione
Prior art date
Application number
SK682-98A
Other languages
English (en)
Slovak (sk)
Inventor
Andreas Huth
Martin Kruger
Eckhard Ottow
Dieter Seidelmann
Roland Neuhaus
Herbert Schneider
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK68298A3 publication Critical patent/SK68298A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK682-98A 1995-11-24 1996-11-15 New quinoxalindione derivatives, their preparation and use in medicaments SK68298A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19545251A DE19545251A1 (de) 1995-11-24 1995-11-24 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
PCT/DE1996/002227 WO1997019066A1 (fr) 1995-11-24 1996-11-15 Nouveaux derives de quinoxaline dione, leur preparation et leur utilisation dans des medicaments

Publications (1)

Publication Number Publication Date
SK68298A3 true SK68298A3 (en) 1998-12-02

Family

ID=7779176

Family Applications (1)

Application Number Title Priority Date Filing Date
SK682-98A SK68298A3 (en) 1995-11-24 1996-11-15 New quinoxalindione derivatives, their preparation and use in medicaments

Country Status (20)

Country Link
EP (1) EP0876357A1 (fr)
JP (1) JP2000500471A (fr)
KR (1) KR19990071596A (fr)
CN (1) CN1202891A (fr)
AU (1) AU720083B2 (fr)
CA (1) CA2238023A1 (fr)
CZ (1) CZ160498A3 (fr)
DE (1) DE19545251A1 (fr)
EE (1) EE9800163A (fr)
HU (1) HUP9902041A3 (fr)
IL (1) IL124534A0 (fr)
IS (1) IS4740A (fr)
MX (1) MX9804068A (fr)
NO (1) NO982349L (fr)
NZ (1) NZ330492A (fr)
PL (1) PL326844A1 (fr)
SK (1) SK68298A3 (fr)
TR (1) TR199800904T2 (fr)
WO (1) WO1997019066A1 (fr)
ZA (1) ZA969832B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19737446A1 (de) * 1997-08-22 1999-02-25 Schering Ag Verfahren zur Herstellung von Phosphonsäurederivaten
EP2338492A1 (fr) 2009-12-24 2011-06-29 Universidad del Pais Vasco Procédés et compositions pour le traitement de la maladie d'Alzheimer
CN106619953A (zh) * 2016-10-31 2017-05-10 山东省海盟生化科技有限公司 一种用于皮肤病的外用中药组合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19519979A1 (de) * 1995-05-24 1996-11-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln

Also Published As

Publication number Publication date
EP0876357A1 (fr) 1998-11-11
EE9800163A (et) 1998-12-15
PL326844A1 (en) 1998-10-26
WO1997019066A1 (fr) 1997-05-29
CZ160498A3 (cs) 1998-09-16
CA2238023A1 (fr) 1997-05-29
AU1867497A (en) 1997-06-11
NO982349L (no) 1998-07-01
AU720083B2 (en) 2000-05-25
TR199800904T2 (xx) 1998-08-21
NO982349D0 (no) 1998-05-22
DE19545251A1 (de) 1997-05-28
JP2000500471A (ja) 2000-01-18
MX9804068A (es) 1998-09-30
KR19990071596A (ko) 1999-09-27
IL124534A0 (en) 1998-12-06
NZ330492A (en) 1999-10-28
IS4740A (is) 1998-05-13
HUP9902041A3 (en) 2000-07-28
HUP9902041A2 (hu) 2000-04-28
ZA969832B (en) 1997-06-17
CN1202891A (zh) 1998-12-23

Similar Documents

Publication Publication Date Title
FI81098B (fi) Foerfarande foer framstaellning av nya terapeutiskt verksamma tiazolidindionderivat.
US4470989A (en) Neuroleptic n-oxacyclyl-alkylpiperidine derivatives
CA2084542A1 (fr) Nouveaux chromanes d'azaheterocyclylmethyle
BG61859B2 (bg) Хинуклидини,метод за получаването и приложението им във фармацевтични препарати
EP0017484B1 (fr) Dérivés de 2-imidazoline, procédé pour leur préparation et leur composition pharmaceutique
JPH0524917B2 (fr)
CZ277698B6 (en) Racemic or optically active bis-aza-bicyclic compounds, process for preparing thereof, intermediates and use thereof
CZ20012637A3 (cs) 2,3,4,5-tetrahydro-1H[1,4]benzodiazepin-3-hydroxamové kyseliny jako inhibitory metaloproteináz mezibuněčné hmoty
EP0177392A1 (fr) Nouvelles (pyridyl-2)-1 pipérazines, leur procédé de préparation et leur application en thérapeutique
WO1996012725A1 (fr) Nouveaux derives de quinoxalinedione, leur preparation et leur utilisation dans des medicaments
JP2005536528A (ja) １−メチル−２−（４−アミジノフェニルアミノメチル）−ベンズイミダゾール−５−イル−カルボン酸−（ｎ−２−ピリジル−ｎ−２−ヒドロキシカルボニルエチル）−アミドの新規プロドラッグ、それらの製造及び医薬組成物としてのそれらの使用
US6143733A (en) Quinoxalinedione derivatives, their production and use in pharmaceutical agents
KR20010079696A (ko) 피라진 화합물
JPH047348B2 (fr)
SK68298A3 (en) New quinoxalindione derivatives, their preparation and use in medicaments
JPH0678302B2 (ja) 新規ピロリジン化合物
US6136805A (en) Quinoxaline dione derivatives, their production and their use in medicaments
CA1156652A (fr) Derives de thiazole, leur preparation et produits pharmaceutiques qui les renferment
RU2140924C1 (ru) Производные пиридо(1,2,3-de)хиноксалина, способы их получения, лекарственное средство
HU193046B (en) Process for preparing aplha-aryl-alpha-pyridyl-alkyl-carboxylic acid derivatives and pharmaceutical compositions
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
SK131795A3 (en) Benzo£f|quinoxalindione derivatives, their preparation and their use in drugs
EP0993461A1 (fr) Nouveaux derives de dione de quinoxaline, leur preparation et leur utilisation dans des medicaments
KR840001285B1 (ko) 2-이미다졸린 유도체류의 제조방법
JP2004518643A (ja) トロンビン阻害剤の製造方法